Question 1

Has Patrick Hayes received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $852,510 in general payments to Patrick Hayes across 1,088 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Patrick Hayes did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Patrick Hayes come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Neurocrine Biosciences, Inc.	319	$306,812
Alkermes, Inc.	409	$287,994
Axsome Therapeutics, Inc.	207	$181,922
E.r. Squibb & Sons, L.L.C.	46	$32,534
Teva Pharmaceuticals USA, Inc.	33	$30,911
Eisai Inc.	29	$11,486
Sunovion Pharmaceuticals Inc.	14	$270
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$139
Takeda Pharmaceuticals U.S.A., Inc.	6	$109
Vanda Pharmaceuticals Inc.	6	$102
Indivior Inc.	3	$64
Noven Therapeutics, LLC	3	$58
Corium, LLC	1	$21
AbbVie	1	$20
Avanir Pharmaceuticals, Inc.	1	$19
Alfasigma USA, Inc.	1	$19
Neuronetics, Inc.	1	$15
Supernus Pharmaceuticals, Inc.	1	$14

Patrick Hayes

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Lake Charles